Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial.

Seminars in Arthritis and Rheumatism
Anna MoltoMaxime Dougados

Abstract

To evaluate the impact of a nurse-led program of systematic screening for the management (detection/prevention) of comorbidities. Prospective, randomized, controlled, open, 12-month trial (NCT02374749). consecutive patients with axial Spondyloarthritis (axSpA) (according to the rheumatologist) THE PROGRAM: A nurse collected data on comorbidities during a specific outpatient visit. In the event of non-agreement with recommendations, the patient was informed and a specific recommendation was given to the patient (orally and in a with a detailed written report). Patients were seen after one year in a nurse-led visit. TREATMENT ALLOCATION: random allocation (i.e. either this program or an educational program not presented here and considered here as the control group). change after one year of a weighted comorbidity management score (0 to 100 where 0= optimal management). 502 patients were included (252 and 250 in the active and control groups, respectively): age: 47±12 years, male gender: 63%, disease duration: 14±11y. After one year, no differences were observed in a weighted comorbidity management score. However, the number of patients in agreement with recommendations was significantly higher in the active group for vaccination...Continue Reading

Associated Clinical Trials

References

Jun 6, 2003·European Heart Journal·R M ConroyUNKNOWN SCORE project group
Jul 16, 2008·Annals of the Rheumatic Diseases·C LukasUNKNOWN Assessment of SpondyloArthritis international Society
May 19, 2009·Annals of the Rheumatic Diseases·L T C van HulstM E J L Hulscher
May 8, 2010·Annals of the Rheumatic Diseases·Maura D IversenNeil Betteridge
Apr 1, 2011·Joint, Bone, Spine : Revue Du Rhumatisme·Clément PratiDaniel Wendling
Jun 21, 2011·Lancet·Maxime Dougados, Dominique Baeten
Nov 1, 2011·Annals of the Rheumatic Diseases·Yvonne van Eijk-HustingsUNKNOWN EULAR
Aug 28, 2016·European Heart Journal·Alberico L CatapanoUNKNOWN ESC Scientific Document Group
Oct 11, 2017·Joint, Bone, Spine : Revue Du Rhumatisme·Charline MourguesMaxime Dougados
Nov 11, 2017·Arthritis Care & Research·E NikiphorouUNKNOWN Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis Study Task Force
Nov 22, 2018·Medicine·Abu-Sayeef MirzaRichard Roetzheim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.